Simple and flexible classification of gene expression microarrays via Swirls and Ripples

Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, EPN 3131, 6130 Executive Blvd MSC 7354, Bethesda, MD 20892-7354, USA.
BMC Bioinformatics (Impact Factor: 2.58). 09/2010; 11(1):452. DOI: 10.1186/1471-2105-11-452
Source: DBLP

ABSTRACT A simple classification rule with few genes and parameters is desirable when applying a classification rule to new data. One popular simple classification rule, diagonal discriminant analysis, yields linear or curved classification boundaries, called Ripples, that are optimal when gene expression levels are normally distributed with the appropriate variance, but may yield poor classification in other situations.
A simple modification of diagonal discriminant analysis yields smooth highly nonlinear classification boundaries, called Swirls, that sometimes outperforms Ripples. In particular, if the data are normally distributed with different variances in each class, Swirls substantially outperforms Ripples when using a pooled variance to reduce the number of parameters. The proposed classification rule for two classes selects either Swirls or Ripples after parsimoniously selecting the number of genes and distance measures. Applications to five cancer microarray data sets identified predictive genes related to the tissue organization theory of carcinogenesis.
The parsimonious selection of classifiers coupled with the selection of either Swirls or Ripples provides a good basis for formulating a simple, yet flexible, classification rule. Open source software is available for download.

1 Follower
7 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We present the extention and application of a new unsupervised statistical learning technique--the Partition Decoupling Method--to gene expression data. Because it has the ability to reveal non-linear and non-convex geometries present in the data, the PDM is an improvement over typical gene expression analysis algorithms, permitting a multi-gene analysis that can reveal phenotypic differences even when the individual genes do not exhibit differential expression. Here, we apply the PDM to publicly-available gene expression data sets, and demonstrate that we are able to identify cell types and treatments with higher accuracy than is obtained through other approaches. By applying it in a pathway-by-pathway fashion, we demonstrate how the PDM may be used to find sets of mechanistically-related genes that discriminate phenotypes.
    BMC Bioinformatics 02/2010; 12(1). DOI:10.1186/1471-2105-12-497 · 2.58 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We define personalized medicine as the administration of treatment to only persons thought most likely to benefit, typically those at high risk for mortality or another detrimental outcome. To evaluate personalized medicine, we propose a new design for a randomized trial that makes efficient use of high-throughput data (such as gene expression microarrays) and clinical data (such as tumor stage) collected at baseline from all participants. Under this design for a randomized trial involving experimental and control arms with a survival outcome, investigators first estimate the risk of mortality in the control arm based on the high-throughput and clinical data. Then investigators use data from both randomization arms to estimate both the effect of treatment among all participants and among participants in the highest prespecified category of risk. This design requires only an 18.1% increase in sample size compared with a standard randomized trial. A trial based on this design that has a 90% power to detect a realistic increase in survival from 70% to 80% among all participants, would also have a 90% power to detect an increase in survival from 50% to 73% in the highest quintile of risk.
    Journal of the National Cancer Institute 11/2010; 102(23):1756-9. DOI:10.1093/jnci/djq427 · 12.58 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Systems biology uses systems of mathematical rules and formulas to study complex biological phenomena. In cancer research there are three distinct threads in systems biology research: modeling biology or biophysics with the goal of establishing plausibility or obtaining insights, modeling based on statistics, bioinformatics, and reverse engineering with the goal of better characterizing the system, and modeling with the goal of clinical predictions. Using illustrative examples we discuss these threads in the context of cancer research.
    Progress in Biophysics and Molecular Biology 03/2011; 106(2):410-3. DOI:10.1016/j.pbiomolbio.2011.03.002 · 2.27 Impact Factor
Show more

Preview (3 Sources)

7 Reads
Available from